Abiopharma

🔍 Trump Donald J. JR (Director)

Company: Trump Media & Technology Group Corp. (DJT)

Report Date: 2026-06-19

Detailed Transactions and Holdings:

• Acquired 23,600 shares of Common Stock, par value $0.0001 per share (Direct)
  Date: 2026-06-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 61,098.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Holds 0 shares of Common Stock, par value $0.0001 per share (Direct)
  Date: 2026-06-19 | Code: H | nature_of_ownership: See Footnote 4 | shares_owned_after: 114,750,000.00 | Footnotes: F4

Footnotes:

• F1: The securities reported are restricted stock units ("RSUs"), each of which represents the contingent right to receive one share of common stock, par value $0.0001 per share (the "common stock") of Trump Media & Technology Group Corp. (the "Issuer")
• F2: Twenty-five percent (25%) of the total number of shares of common stock underlying the RSUs shall vest in four (4) substantially equal quarterly installments beginning June 25, 2026, and ending March 25, 2027. Settlement and delivery of common stock following vesting of each installment is subject to the terms and conditions of the RSU award agreement and the Issuer's 2024 Amended & Restated Equity Incentive Plan (the "Plan").
• F3: Certain of the securities reported in Column 5 of Table I are RSUs. Each RSU represents a contingent right to receive one share of common stock, subject to the applicable vesting schedule and conditions of each RSU award agreement and the Plan.
• F4: These shares are held directly by the Donald J. Trump Revocable Trust Dated April 7, 2014 (the "Trust"), of which the reporting person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The reporting person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.